AVEO Pharmaceuticals

YTD

ALL

Why Robinhood?

You can watch AVEO and buy or sell other stocks, ETFs, and their options commission-free!

About AVEO

AVEO Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the advancement of therapeutics for oncology, and other areas of unmet medical need. Its product candidates include Tivozanib, Ficlatuzmab, AV-203, AV-380 and AV-353.

CEO

Michael P. Bailey, MBA

CEOMichael P. Bailey, MBA

Employees

—

Employees—

Headquarters

Boston, Massachusetts

HeadquartersBoston, Massachusetts

Founded

2001

Founded2001

Employees

—

Employees—

AVEO Key Statistics

Market cap

521.45M

Market cap521.45M

Price-Earnings ratio

-17.81

Price-Earnings ratio-17.81

Dividend yield

—

Dividend yield—

Average volume

545.54K

Average volume545.54K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$15.00

52 Week high$15.00

52 Week low

$3.06

52 Week low$3.06

People also own

Based on the portfolios of people who own AVEO. This list is generated using Robinhood data, and it’s not a recommendation.